Underwriter (Number Of Offerings As Lead/Number of Offerings As Lead Or Comanager) |
After-Market Performance (Average)** |
Lehman Brothers (0/1) | +128% |
Pacific Growth Equities Inc. (0/1) | +128% |
A.G. Edwards & Sons Inc. (0/1) | +96% |
BancBoston Robertson Stephens (1/3) | +95% |
CIBC Oppenheimer Corp. (1/1) | +90% |
Nesbitt Burns Inc. (0/1) | +90% |
Donaldson, Lufkin & Jenrette (1/1) | +85% |
Warburg Dillon Read LLC (0/3) | +84% |
First Marathon Securities Inc. (1/1) | +80% |
Goldman, Sachs & Co. (0/1) | +77% |
Merrill Lynch & Co. (0/1) | +77% |
ING Baring Furman Selz LLC (2/3) | +74% |
Deutsche Banc Alex. Brown (1/3) | +73% |
China Everbright Securities Ltd. (0/1) | +70% |
The New China Hong Kong Securities Ltd. (0/1) | +70% |
Westport Resources Investment Services Inc. (1/1) | +70% |
Prudential Vector Securities (1/2) | +68% |
S.G. Cowen Securities Corp. (0/3) | +57% |
Credit Suisse First Boston Corp. (1/1) | +54% |
Dain Rauscher Wessels (0/1) | +54% |
Legg Mason Wood Walker Inc. (0/1) | +54% |
U.S. Bancorp Piper Jaffray (1/2) | +70% |
Hambrecht & Quist LLC# (1/3) | +50% |
HSBC James Capel Canada Inc. (0/2) | +47% |
Punk, Ziegel & Co. (0/1) | +40% |
Morgan Stanley & Co. (1/1) | +34% |
J.P. Morgan & Co. (2/2) | +27% |
Cruttendon Roth Inc. (1/1) | +24% |
Leerink Swann & Co. (0/1) | +23% |
Schroders Securities Ltd. (0/1) | +23% |
Vontobel Securities Ltd. (0/1) | +23% |
Robert Fleming & Co. Ltd. (1/1) | +17% |
Canaccord Capital Corp. (0/1) | +14% |
TD Securities Inc. (1/1) | +14% |
Loewen, Ondaatje, McCutcheon Ltd. (0/2) | -20% |
Adams, Harkness & Hill Inc. (0/1) | -23% |
Robert W. Baird & Co. (0/1) | -23% |
Levesque Beaubien Geoffrion Inc. (1/1) | -53% |
Notes | |
*The offerings in this chart include those that were completed on U.S. stock exchanges (NASDAQ, NYSE, or AMEX), the Canadian Stock Exchange (TSE) and the London Stock Exchange (LSE) from January-July 1999. Gross proceeds exclude additional funding raised from the excerise of overallotment options | |
**After-market performance is expressed as the percent-change in stock price between the IPO price and the closing price on 8/25/99. For underwriters with multiple offerings, the after-market performance (as a percent change) was calculated for each stock in the underwriter's "group," the percentage summed, and then averaged. # Hambrecht & Quist LLC acted as placement agent for Ribozyme Pharmaceutical Inc.'s 7/99 follow-on offering. | |
